Skip to content

Clinical trials

Prostatic Hyperplasia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Hyperplasia Clear all

805 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20014
20025
200310
200416
200524
200623
200721
200821
200929
201031
201126
201224
201338
201439
201539
201626
201728
201826
201927
202033
202150
202242
202332
202446
202551
202680

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed446
Unknown status106
Recruiting91
Not yet recruiting62
Terminated40
Active, not recruiting31
Withdrawn21
Enrolling by invitation5
Suspended3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline43
Boehringer Ingelheim18
Eli Lilly and Company17
Mansoura University15
Ain Shams University12
Samsung Medical Center12
Beni-Suef University11
Sanofi11
Boston Scientific Corporation10
Chinese University of Hong Kong10

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Hyperplasia805
Lower Urinary Tract Symptoms146
Prostatic Neoplasms60
Urinary Bladder, Overactive23
Urinary Bladder Neck Obstruction21
Erectile Dysfunction20
Urinary Retention19
Urinary Incontinence15
Urinary Bladder Neoplasms14
Prostatic Diseases13

Trials

Showing 51 to 75 of 805. Each trial links to its page on Pharma Observatory.

705 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.